Cargando…
Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats
Background: The hypothalamus is an important brain region for the regulation of energy balance. Roux-en-Y gastric bypass (RYGB) surgery and gut hormone-based treatments are known to reduce body weight, but their effects on hypothalamic gene expression and signaling pathways are poorly studied. Metho...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746874/ https://www.ncbi.nlm.nih.gov/pubmed/35010991 http://dx.doi.org/10.3390/nu14010116 |
_version_ | 1784630695342112768 |
---|---|
author | Dischinger, Ulrich Heckel, Tobias Bischler, Thorsten Hasinger, Julia Königsrainer, Malina Schmitt-Böhrer, Angelika Otto, Christoph Fassnacht, Martin Seyfried, Florian Hankir, Mohammed Khair |
author_facet | Dischinger, Ulrich Heckel, Tobias Bischler, Thorsten Hasinger, Julia Königsrainer, Malina Schmitt-Böhrer, Angelika Otto, Christoph Fassnacht, Martin Seyfried, Florian Hankir, Mohammed Khair |
author_sort | Dischinger, Ulrich |
collection | PubMed |
description | Background: The hypothalamus is an important brain region for the regulation of energy balance. Roux-en-Y gastric bypass (RYGB) surgery and gut hormone-based treatments are known to reduce body weight, but their effects on hypothalamic gene expression and signaling pathways are poorly studied. Methods: Diet-induced obese male Wistar rats were randomized into the following groups: RYGB, sham operation, sham + body weight-matched (BWM) to the RYGB group, osmotic minipump delivering PYY3-36 (0.1 mg/kg/day), liraglutide s.c. (0.4 mg/kg/day), PYY3-36 + liraglutide, and saline. All groups (except BWM) were kept on a free choice of high- and low-fat diets. Four weeks after interventions, hypothalami were collected for RNA sequencing. Results: While rats in the RYGB, BWM, and PYY3-36 + liraglutide groups had comparable reductions in body weight, only RYGB and BWM treatment had a major impact on hypothalamic gene expression. In these groups, hypothalamic leptin receptor expression as well as the JAK–STAT, PI3K-Akt, and AMPK signaling pathways were upregulated. No significant changes could be detected in PYY3-36 + liraglutide-, liraglutide-, and PYY-treated groups. Conclusions: Despite causing similar body weight changes compared to RYGB and BWM, PYY3-36 + liraglutide treatment does not impact hypothalamic gene expression. Whether this striking difference is favorable or unfavorable to metabolic health in the long term requires further investigation. |
format | Online Article Text |
id | pubmed-8746874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87468742022-01-11 Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats Dischinger, Ulrich Heckel, Tobias Bischler, Thorsten Hasinger, Julia Königsrainer, Malina Schmitt-Böhrer, Angelika Otto, Christoph Fassnacht, Martin Seyfried, Florian Hankir, Mohammed Khair Nutrients Article Background: The hypothalamus is an important brain region for the regulation of energy balance. Roux-en-Y gastric bypass (RYGB) surgery and gut hormone-based treatments are known to reduce body weight, but their effects on hypothalamic gene expression and signaling pathways are poorly studied. Methods: Diet-induced obese male Wistar rats were randomized into the following groups: RYGB, sham operation, sham + body weight-matched (BWM) to the RYGB group, osmotic minipump delivering PYY3-36 (0.1 mg/kg/day), liraglutide s.c. (0.4 mg/kg/day), PYY3-36 + liraglutide, and saline. All groups (except BWM) were kept on a free choice of high- and low-fat diets. Four weeks after interventions, hypothalami were collected for RNA sequencing. Results: While rats in the RYGB, BWM, and PYY3-36 + liraglutide groups had comparable reductions in body weight, only RYGB and BWM treatment had a major impact on hypothalamic gene expression. In these groups, hypothalamic leptin receptor expression as well as the JAK–STAT, PI3K-Akt, and AMPK signaling pathways were upregulated. No significant changes could be detected in PYY3-36 + liraglutide-, liraglutide-, and PYY-treated groups. Conclusions: Despite causing similar body weight changes compared to RYGB and BWM, PYY3-36 + liraglutide treatment does not impact hypothalamic gene expression. Whether this striking difference is favorable or unfavorable to metabolic health in the long term requires further investigation. MDPI 2021-12-28 /pmc/articles/PMC8746874/ /pubmed/35010991 http://dx.doi.org/10.3390/nu14010116 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dischinger, Ulrich Heckel, Tobias Bischler, Thorsten Hasinger, Julia Königsrainer, Malina Schmitt-Böhrer, Angelika Otto, Christoph Fassnacht, Martin Seyfried, Florian Hankir, Mohammed Khair Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats |
title | Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats |
title_full | Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats |
title_fullStr | Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats |
title_full_unstemmed | Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats |
title_short | Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats |
title_sort | roux-en-y gastric bypass and caloric restriction but not gut hormone-based treatments profoundly impact the hypothalamic transcriptome in obese rats |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746874/ https://www.ncbi.nlm.nih.gov/pubmed/35010991 http://dx.doi.org/10.3390/nu14010116 |
work_keys_str_mv | AT dischingerulrich rouxenygastricbypassandcaloricrestrictionbutnotguthormonebasedtreatmentsprofoundlyimpactthehypothalamictranscriptomeinobeserats AT heckeltobias rouxenygastricbypassandcaloricrestrictionbutnotguthormonebasedtreatmentsprofoundlyimpactthehypothalamictranscriptomeinobeserats AT bischlerthorsten rouxenygastricbypassandcaloricrestrictionbutnotguthormonebasedtreatmentsprofoundlyimpactthehypothalamictranscriptomeinobeserats AT hasingerjulia rouxenygastricbypassandcaloricrestrictionbutnotguthormonebasedtreatmentsprofoundlyimpactthehypothalamictranscriptomeinobeserats AT konigsrainermalina rouxenygastricbypassandcaloricrestrictionbutnotguthormonebasedtreatmentsprofoundlyimpactthehypothalamictranscriptomeinobeserats AT schmittbohrerangelika rouxenygastricbypassandcaloricrestrictionbutnotguthormonebasedtreatmentsprofoundlyimpactthehypothalamictranscriptomeinobeserats AT ottochristoph rouxenygastricbypassandcaloricrestrictionbutnotguthormonebasedtreatmentsprofoundlyimpactthehypothalamictranscriptomeinobeserats AT fassnachtmartin rouxenygastricbypassandcaloricrestrictionbutnotguthormonebasedtreatmentsprofoundlyimpactthehypothalamictranscriptomeinobeserats AT seyfriedflorian rouxenygastricbypassandcaloricrestrictionbutnotguthormonebasedtreatmentsprofoundlyimpactthehypothalamictranscriptomeinobeserats AT hankirmohammedkhair rouxenygastricbypassandcaloricrestrictionbutnotguthormonebasedtreatmentsprofoundlyimpactthehypothalamictranscriptomeinobeserats |